Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4616)
  2. Surgery (3551)
  3. Survivorship Research (2660)
  4. Solid Tumor Oncology Division (2653)
  5. Radiation Oncology, Department of (2126)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1673)
  8. Hematologic Malignancies, Division of (1612)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7392)
  2. Meeting Abstract (4717)
  3. Review (624)
  4. Book Section (538)
  5. Editorial (253)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4616)
  2. Surgery (3551)
  3. Survivorship Research (2660)
  4. Solid Tumor Oncology Division (2653)
  5. Radiation Oncology, Department of (2126)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (378)

More People

Years
  1. 2025 (290)
  2. 2024 (784)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2614)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (971)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (436)

More Publications

Results (13894)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic mapping of metastatic organotropism: Analysis of 2326 primary and organ-specific metastases in lung adenocarcinoma
    Meeting Abstract

    Lengel, H.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Defining morphologic features of invasion in pulmonarynon-mucinousadenocarcinoma with lepidic growth
    Meeting Abstract

    Thunnissen, E; Borczuk, A.; Beasly, M. B.; Tsao, M.; Kerr, K.; Dacic, S.; Minami, Y.; Nicholson, A.; Lissenberg-Witte, B.; Roden, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1 fusion-positive (ROS1-fp) NSCLC: Updated efficacy and safety analysis
    Meeting Abstract

    Fan, Y.; Drilon, A.; Chiu, C. H.; Bowles, D. W.; Loong, H. H. F.; Siena, S.; Goto, K.; Krzakowski, M.; Ahn, M. J.; Murakami, H.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of sapanisertib and telaglenastat (CB-839) in patients with advanced NSCLC (NCI 10327): Results from dose escalation
    Meeting Abstract

    Riess, J.; Frankel, P.; Massarelli, E.; Nieva, J.; Lai, W. C. V.; Koczywas, M.; Shackelford, D.; Lanza, I.; Reid, J. M.; Gonsalves, W. I.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • CodeBreaK 100/101: First report of safety/efficacy of sotorasib in combination with pembrolizumab or atezolizumab in advanced KRAS p.G12C NSCLC
    Meeting Abstract

    Li, B. T.; Falchook, G. S.; Durm, G. A.; Burns, T. F.; Skoulidis, F.; Ramalingam, S. S.; Spira, A.; Bestvina, C. M.; Goldberg, S. B.; Veluswamy, R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 updated exploration and first expansion data for DLL3-targeted T-cell engager tarlatamab in small cell lung cancer
    Meeting Abstract

    Borghaei, H.; Paz-Ares, L.; Johnson, M.; Champiat, S.; Owonikoko, T.; Lai, V.; Boyer, M.; Hummel, H. D.; Govindan, R.; Steeghs, N.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • First-line pembrolizumab or placebo combined with etoposide and platinum for ES-SCLC: KEYNOTE-604 long-term follow-up results
    Meeting Abstract

    Rudin, C. M.; Kim, H. R.; Navarro, A.; Gottfried, M.; Peters, S.; Csőszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Czyżewicz, G.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • T-cell dynamics in response to neoadjuvant atezolizumab in early NSCLC by antigen response and T-cell receptor sequencing
    Meeting Abstract

    Oezkan, F.; Hilz, S.; Grindheim, J.; Wallace, A.; Seweryn, M.; Reuben, A.; Zhang, J.; Owen, D. H.; Nicholas, A.; Yadav, M.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Lobar or sub-lobar resection for peripheral clinical stage IA = 2 cm non-small cell lung Cancer (NSCLC): Results from an international randomized phase III trial (CALGB 140503 [Alliance])
    Meeting Abstract

    Altorki, N. K.; Wang, X.; Kozono, D.; Watt, C.; Landreneau, R.; Wigle, D.; Port, J.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save